title: Study of Isobaric Interference in Quantification of Citrulline by Parallel Fragmentation Monitoring.
abstract: Parallel Fragmentation Monitoring (PFM), which is an analogue of selected reaction monitoring (SRM), is a recently developed method for quantification of small molecules by MALDI-TOF/TOF mass spectrometry (MS). It is well known that isobaric interference substances can be occasionally present in complex biological samples, and affect the accuracy of measurement by SRM. Unfortunately, by design it is not possible to assess whether isobaric interference happens in a SRM analysis. In contrast, the unique design of PFM should allow quick inspection for isobaric interference and subsequent correction. In this study, using arginine as an example, interference effect of isobaric structural analogs on the quantification of citrulline by PFM was evaluated. Our results showed that the presence of arginine affected the measured concentrations of citrulline standard solutions in a concentration dependent manner. Such interference could be observed readily in the MS/MS spectra, and contributed by [arginine+H-NH3](+) fragment ion. Because of having highly similar mass, (13)C-isotope of [arginine+H-NH3](+) fragment ion overlapped with monoisotope of [citrulline+H-NH3](+) fragment ion, which was used as the report ion for quantification. However, such interference could be mathematically eliminated or minimized through estimation of the signal intensity of the (13)C-isotopic peak of [arginine+H-NH3](+) from the intensity of the corresponding monoisotopic peak according to isotope distribution of elements. Furthermore, the presence of interfering fragment ions could be avoided by optimizing MALDI ionization condition. In conclusion, isobaric interference can happen in PFM, but can be easily identified in the mass spectra and eliminated (minimized) with simple methods.
authors.affiliation: Department of Pediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital.
authors.forename: Eddy Wing Yin
authors.initials: EW
authors.lastname: Ng
authors.affiliation: Department of Pediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital.
authors.forename: Hugh Simon
authors.initials: HS
authors.lastname: Lam
authors.affiliation: Department of Pediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital.
authors.forename: Pak Cheung
authors.initials: PC
authors.lastname: Ng
authors.affiliation: Department of Pediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital.
authors.forename: Terence Chuen Wai
authors.initials: TC
authors.lastname: Poon
keywords: MALDI-TOF/TOF MS; amino acid; isobaric interference; parallel fragmentation monitoring; quantification
references.citation: Methods Mol Biol. 2012;828:121-35
references.pmid: 22125142
references.citation: Clin Chem. 2010 Feb;56(2):291-305
references.pmid: 20022980
references.citation: Methods. 2013 Jun 15;61(3):299-303
references.pmid: 23707623
references.citation: J Chromatogr A. 2004 May 21;1036(2):161-9
references.pmid: 15146917
references.citation: Rapid Commun Mass Spectrom. 2009 May;23(10):1483-92
references.pmid: 19350529
references.citation: Rapid Commun Mass Spectrom. 2005;19(14):1943-50
references.pmid: 15954168
references.citation: Rapid Commun Mass Spectrom. 2010 Jul 15;24(13):1902-10
references.pmid: 20533320
references.citation: Rapid Commun Mass Spectrom. 2006;20(10 ):1517-24
references.pmid: 16628567
references.citation: J Am Soc Mass Spectrom. 2007 Feb;18(2):279-84
references.pmid: 17074506
references.citation: Rapid Commun Mass Spectrom. 2005;19(12):1587-602
references.pmid: 15915446
references.citation: J Anal Toxicol. 2008 Oct;32(8):709-14
references.pmid: 19007526
references.citation: Anal Chem. 2005 Sep 1;77(17):5643-54
references.pmid: 16131077
references.citation: Rapid Commun Mass Spectrom. 2003;17(12):1297-311
references.pmid: 12811753
references.citation: Clin Chem. 2010 Aug;56(8):1234-44
references.pmid: 20511452
references.citation: Rapid Commun Mass Spectrom. 2008 Jul;22(13):2021-8
references.pmid: 18512848
references.citation: Clin Chim Acta. 2013 May;420:121-7
references.pmid: 23123829
references.citation: Ther Drug Monit. 2005 Dec;27(6):747-51
references.pmid: 16404815
references.citation: Mol Syst Biol. 2008;4:222
references.pmid: 18854821
references.citation: Mass Spectrom Rev. 2006 Nov-Dec;25(6):866-80
references.pmid: 16752429
references.citation: Anal Chem. 2004 Sep 1;76(17):5092-6
references.pmid: 15373447